Skip to content

Comparison of two drug combination for Laparoscopic Cholecystectomy for post operative pain relief

Comparison of intravenous lignocaine with intravenous lignocaine and Magnesium Sulphate combination for Laparoscopic Cholecystectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039789
Enrollment
50
Registered
2022-01-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Post op infusion of lignocaine and magnesium sulphate: These patients will receive the combination of intravenous lignocaine and magnesium sulphate 50mg/kg in bolus of 50 ml and maintai

Sponsors

Dr Alok Kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients aged 18 to 50 years of both sex undergoing laproscopic cholecystectomy under general anesthesia. 2)ASA 1 and 2. 3)Consenting patients

Exclusion criteria

Exclusion criteria: 1)Patient refusal 2)ASA 3 & 4 3)Allergy to drugs 4)Seropositive and COVID 19 positive

Design outcomes

Primary

MeasureTime frame
1)Quality of recovery score in post operative laproscopic cholecystectomy over 24 hours 2)To compare post-operative analgesia in the group with lignocaine and a group with combination of lignocaine and magnesium sulphate by NRS score at 0, 2, 4, 12 and 24 hour.Timepoint: 1)Quality of recovery score in post operative laproscopic cholecystectomy over 24 hours 2)To compare post-operative analgesia in the group with lignocaine and a group with combination of lignocaine and magnesium sulphate by NRS score at 0, 2, 4, 12 and 24 hour.

Secondary

MeasureTime frame
To compare hemodynamics between the two groups intra-operatively and post operatively.Timepoint: Intar-operative and post- operative for 24 hours

Countries

India

Contacts

Public ContactDr Alok Kumar

IGIMS

alok4138starex@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026